Related content

Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis

By Dane Cem   Dane Banu   Cetin Ahmet   Erginbas Murat  

Gynecological Endocrinology, Vol. 23, Iss. 7, 2007-07 ,pp. : 398-403

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of the effects of vitamin D receptor and estrogen receptor 1 gene polymorphisms on bone mineral density in postmenopausal women

By Durusu Tanriover Mine   Bora Tatar Gamze   Uluturk Tenzile   Dayangac Erden Didem   Tanriover Altug   Kilicarslan Alpaslan   Oz S.   Erdem Yurter Hayat   Sozen Tumay   Sain Guven Gulay  

Clinical Rheumatology, Vol. 29, Iss. 11, 2010-11 ,pp. : 1285-1293

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen Receptor  Dinucleotide (CA) Repeat Polymorphism is Significantly Associated with Bone Mineral Density in Postmenopausal Women

By Scariano J.  

Calcified Tissue International, Vol. 74, Iss. 6, 2004-06 ,pp. : 501-508

Springer Publishing Company

Access to resources Recommend Favorite

Effects of specific post‐menopausal hormone therapies on bone mineral density in post‐menopausal women: a meta‐analysis

By Dören Martina  

Human Reproduction, Vol. 18, Iss. 8, 2003-08 ,pp. : 1737-1746

Oxford University Press

Access to resources Recommend Favorite

Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis

By Iwamoto Jun   Takeda Tsuyoshi   Sato Yoshihiro   Uzawa Mitsuyoshi  

Clinical Rheumatology, Vol. 23, Iss. 5, 2004-10 ,pp. : 383-389

Springer Publishing Company

Access to resources Recommend Favorite